Literature DB >> 25874199

The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-Analysis.

Jianjun Jiang1, Yanjiao Li1, Lifen Dai2, Haiying Wu3, Min Hu1.   

Abstract

Entities:  

Year:  2015        PMID： 25874199      PMCID： PMC4383517          DOI： 10.1155/2015/597413

Source DB:  PubMed          Journal:  Int J Genomics        ISSN： 2314-436X            Impact factor:   2.326


× No keyword cloud information.
  4 in total

1.  Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer.

Authors:  Maha Rebaï; Imen Kallel; Fatma Hamza; Salma Charfeddine; Raja Kaffel; Fadhel Guermazi; Ahmed Rebaï
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

2.  A two-stage case-control study of EGFR polymorphisms and breast cancer risk.

Authors:  Young-Seoub Hong; Sandra L Deming; Yu-Tang Gao; Ji-Rong Long; Xiao-Ou Shu; Qiuyin Cai; Wei Lu; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

3.  A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.

Authors:  Yinsheng Wang; Lidan Zha; Dan Liao; Xiaozhi Li
Journal:  Int J Genomics       Date:  2014-10-21       Impact factor: 2.326

4.  HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.

Authors:  Naglaa R AbdRaboh; Hanan H Shehata; Manal B Ahmed; Fatehia A Bayoumi
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.